Alungrib Brigatinib 30 mg


Alungrib is a cancer medicine which is used to treat non-small cell lung cancer, anaplastic lymphoma kinase (ALK). It is also used to treat cancer that has certain abnormal gene. This medicine works by interfering with the growth and spread of cancer cells in the body. To buy Alungrib or to know its price contact 3S Corporaton.

Manufacturer : Takeda Pharmaceutical


Strengths available30 mg

Form :  Tablets

Dosage :  Usual Adult Dose for Non-Small Cell Lung Cancer: -Initial Dose: 90 mg orally once a day for the first 7 days. Maintenance Dose: If initial dose is tolerated during the first 7 days, increase to 180 mg orally once a day. Duration of Therapy: Until disease progression or unacceptable toxicity.

Storage :  Store at controlled room temperature 20°C to 25°C

Is the medicine US FDA  approved : Yes

Date of Approval : 28 April, 2017



Common side effects are nausea, diarrhea, cough, headache or feeling tired.

Serious side effects are  lung  problems, vision problem, high blood pressure, high blood sugar, very slow heartbeats, muscle damage or pancreatitis.


Pack of 180 tablets


There are no reviews yet.

Be the first to review “Alungrib Brigatinib 30 mg”

Your email address will not be published. Required fields are marked *